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242 F. Gubert et al.BCCL group. Interestingly, brain-derived neurotrophic factor (BDNF) expression was up-regulated in the SVZ in the treated animals,
but not in the other groups. These data thus suggest that BMMC transplantation modulates the phenotype of RGLCs/progenitors in
the SVZ and could have a protective role after ischemia.
© 2012 Elsevier B.V. All rights reserved.Introduction
Radial glia cells play important roles in neuronal migration and
neurogenesis during development (Kriegstein and Alvarez-
Buylla, 2009; Malatesta et al., 2003; Noctor et al., 2001).
These cells have their cell bodies in the ventricular zone, and
radial processes extending to the pial surface. By the end
of the developmental period, most of the radial glia cells
differentiate into astrocytes (Alves et al., 2002; Levitt and
Rakic, 1980; Mission et al., 1991; Voigt, 1989). During de-
velopment, radial glia cells correspond to the neural stem
cells (NSCs), since they are able to proliferate, self-renew, and
also differentiate into neurons, astrocytes and oligodendro-
cytes (Anthony et al., 2004; Costa et al., 2010; Merkle et al.,
2004; Noctor et al., 2001, 2002; Spassky et al., 2005). It has also
been shown that radial glia cells originate resident NSCs in the
subventricular zone (SVZ) in the adult brain (Merkle et al.,
2004). There are two regions in the mammalian brain where
neurogenesis persists during adulthood: the SVZ, around the
lateral ventricles (LV); and the subgranular layer (SGL) of the
hippocampal dentate gyrus (DG) (Gage, 2000; Gage et al.,
1998; Kaplan and Bell, 1984; Kriegstein and Alvarez-Buylla,
2009; Lois and Alvarez-Buylla, 1993).
Recently, we and others demonstrated that cells with
astroglial characteristics and radial processes are still
present in specific regions of the adult brain. These cells
are termed radial glia-like cells (RGLCs) and they are present
in the SVZ and in the SGL (Alvarez-Buylla et al., 2002; Gubert
et al., 2009; Shapiro et al., 2005; Sundholm-Peters et al.,
2004). In the SVZ, we have shown that RGLCs can be
identified by their radial morphology, with the cell body in
the SVZ and long processes extending to the striatum. These
cells express vimentin, nestin, astrocyte-specific glutamate
transporter (GLAST) and Pax6, well-known markers of radial
glia cells during development (Gubert et al., 2009), and
similarly to these cells, they seem to have NSC character-
istics in the SVZ (Gubert et al., 2009; Mirzadeh et al., 2008).
Several groups have studied the response of NSCs to
injury or neurodegenerative diseases. In pathological condi-
tions that cause neuronal death, such as cerebral ischemia,
epilepsy or traumatic brain injury, neurogenesis increases in
the SVZ and in the SGL (Barkho and Zhao, 2011; Dash et al.,
2001; Kokaia et al., 2006; Li et al., 2002; Liu et al., 1998). In
these conditions, the newly formed neurons are attracted
and migrate to the lesion site (Arvidsson et al., 2002; Jin
et al., 2003; Kokaia et al., 2006; Parent et al., 2002; Zhang
et al., 2001). After an injury that affects glial cells such
as oligodendrocytes, a similar response is observed; NSC
proliferation increases and newly formed oligodendrocyte
progenitors migrate to the lesion (Gonzalez-Perez and
Alvarez-Buylla, 2011; Menn et al., 2006; Picard-Riera et
al., 2002). However, even though the endogenous NSCs
respond to injuries, this increase in proliferation isinsufficient to replace a significant number of the lost
cells. In an attempt to regenerate or protect neural cells
after injury, several research groups are testing therapies
with stem cells in animal models and humans (Barbosa da
Fonseca et al., 2009, 2010; Friedrich et al., 2012;
Pimentel-Coelho and Mendez-Otero, 2010; Rost et al.,
2012; Thwaites et al., 2012). One of the sources of stem
cells used is bone marrow, and several studies using animal
models of neurological diseases have shown that these cells
can attenuate the functional loss after an injury to the
nervous system (de Vasconcelos Dos Santos et al., 2010;
Giraldi-Guimaraes et al., 2012; Li et al., 2006;
Ribeiro-Resende et al., 2009; Vasconcelos-Dos-Santos et
al., 2012; Zaverucha-do-Valle et al., 2011).
Although the mechanisms involved in the therapeutic
effects described above are still subject to debate, it is
accepted that these cells migrate to the lesion area and
probably release neuroprotective and/or trophic factors
that may have neuroprotective and/or neuroregenerative
functions. In this respect, several studies have demonstrated
that bone-marrow therapy reduces cell death, glial scar
formation, microglial activation and inflammation, protects
the tissue against insult, and also stimulates axonal growth
(Costa-Ferro et al., 2012; de Vasconcelos Dos Santos et al.,
2010; Li et al., 2005; Ohtaki et al., 2008; Ribeiro-Resende et
al., 2009; Schwarting et al., 2008; Zaverucha-do-Valle et al.,
2011). It has also been demonstrated that bone-marrow
therapy increases the proliferation of NSCs in the SVZ and
SGL (Chen et al., 2003; Kan et al., 2011), and some growth
factors such as vascular endothelial growth factor (VEGF),
epidermal growth factor (EGF) or fibroblast growth factor-2
(FGF-2) have been found to be related to this event (Cao
et al., 2004; Craig et al., 1996; Doetsch et al., 2002; Sun
et al., 2009). In addition, infusion of growth factors could
also increase the number of RGLCs in the SVZ of adult mice
(Gregg and Weiss, 2003).
In the present study, we subjected adult rats to chronic
cerebral hypoperfusion, a model of global cerebral ischemia
that decreases the cerebral blood flow to about 25 to 94% of
the normal levels (Tsuchiya et al., 1992) and causes damage
mainly in the white matter (Kurumatani et al., 1998; Wakita
et al., 2002). We investigated if in this model of moderate
brain injury, intravenously injected bone-marrow cells
migrate to the brain and have any effect on the SVZ, an
important NSC niche in the adult brain.Materials and methods
Animals
Adult (3–5 month-old) male Lister hooded rats were obtained
from our breeding colony. All experiments were performed in
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the Care and Use of Laboratory Animals, andwere approved by
the Committee for the Use of Experimental Animals of our
Institution.
Global cerebral ischemia
The rats were anesthetizedwith xylazine (5 mg/kg, Vetbrands)
and ketamine (50 mg/kg, Vetbrands) i.p. Experimental ische-
mia was induced by bilateral ligation of the common carotids
(BCCL) performed by tying and cutting the artery, permanently
blocking the blood flow. The sham-operated group received
the same surgical procedure without the carotid ligation. After
recovery from anesthesia, the animals from both groups were
returned to the animal facility and kept in cages with food and
water ad libitum for 3, 7 or 21 days.
Isolation and labeling of mononuclear bone-marrow
cells
Bone-marrow cells were obtained from the femur and tibia of
adult rats. The epiphyses were cut and the marrow was
extruded with 10 ml of Dulbecco's modified Eagle's medium
(DMEM; Invitrogen Inc., Carlsbad, CA, USA). Bone-marrow
mononuclear cells (BMMCs) were isolated by density gradient
(Histopaque 1083; Sigma, St. Louis, MO, USA) andwashed three
times with phosphate buffered saline (PBS). We suspended
2×107 cells in 400 μl of saline and injected this into the tail
vein 24 h post-surgery, in both the ischemic and sham-
operated groups.
In a group of animals, the BMMCs were labeled with a
fluorescent marker (CellTrace™ Far Red DDAO-SE; Invitrogen)
or with the radioactive tracer technecium 99 m (Tc99m)
before transplantation. For fluorescent labeling, cells were
incubated with Cell Trace (1:500 diluted in DMEM) for 40 min
at 37 °C, washed 5 times with PBS and then resuspended in
saline. For the Tc99m labeling, cells were first incubated with
a SnCl2 solution (12 μg/ml) for 10 min, followed by incubation
with Tc99m for 10 min, and then washed three times in saline
according to previously described protocols (Barbosa da
Fonseca et al., 2010; Gutfilen et al., 1999). After transplan-
tation, the biodistribution of the radioactive-labeled cells was
detected in the animals with a GE Millennium gamma camera
(General Electric Medical Systems, Milwaukee, WI, USA) 1 h
after injection.
Analysis of mononuclear bone-marrow cells using
flow cytometry
The BMMC population used in the transplant procedure was
characterized by flow cytometry. For this, cells were incubat-
ed for 20 minwith the following antibodies: anti-CD11b/c-FITC
(fluorescein isothiocyanate; Caltag Laboratories-Invitrogen),
anti-CD29-FITC, anti-CD45-phycoerythrin-cyanine 5 (PE-CY5),
anti-Gran-1-FITC and anti-CD90-PE (from BD Biosciences, San
Jose, CA, USA). Next, we used a lysing solution (BD Lysing
Solution, BD Biosciences) to lyse erythrocytes, and fixed the
cells. The cells were then washed in PBS before analysis in a
flow cytometer (BD FACSAria, BD Biosciences). All antibody
dilutions were 1:100 in PBS. Data analyses were performed
using Infinicyt 1.2 software (Cytognos).Tissue preparation and immunohistochemistry
Animals were perfused through the heart with ice-cold
saline, followed by a solution of 4% paraformaldehyde
in 0.1 M phosphate buffer, pH 7.4, via the ascending aorta.
The brains were then removed, cryoprotected by immersion
in 20% sucrose, sectioned at 20 μm on a cryostat (Leica, CM
1850) and collected on gelatin-coated slides. For immuno-
histochemistry, sections were washed three times with PBS
with 0.1%–0.3% Triton X-100, incubated with 5% normal goat
serum (NGS — Sigma) in PBS for 30 min and then incubated
with the primary antibodies overnight at 4 °C. The following
antibodies were used: mouse monoclonal antibody against
vimentin (1:150; Chemicon, Temecula, CA, USA), mouse
monoclonal antibody against nestin (1:200; Abcam); rabbit
polyclonal antibody against NG2 (1:50; Millipore, MA, USA);
and guinea pig polyclonal antibody against doublecortin
(DCX — 1:1500; Chemicon). After primary incubations,
the appropriate secondary, Cy3®- or Alexa® 488-conjugated
antibodies (Jackson ImmunoResearch, West Grove, PA, USA
and Invitrogen, respectively) were used. In some cases, the
sections were incubated with TO-PRO®-3 (1:1000; Invitrogen)
to stain the nuclei. Sections were mounted with VectaShield
(Vector, Burlingame, CA, USA) and analyzed with the aid of
confocal microscopes (Zeiss LSM 510 Meta or LSM 510 Meta
NLO, GmbH, Germany).Neuronal degeneration analysis using FluoroJade C
Neuronal cell death was evaluated 3 days post-surgery, with
FluoroJade C staining (Histo-Chem Inc., Jefferson, AR, USA).
For this, sections were washed in distilled water, air-dried at
45 °C for 30 min and then washed consecutively with 100%
and 70% ethanol followed by distilled water (for 1 min each).
The sections were then immersed in a 0.06% potassium
permanganate solution in distilled water for 15 min, rinsed
with distilled water 3 times for 1 min each time, and
incubated in a 0.001% FluoroJade C solution in 0.1% acetic
acid for 30 min. The sections were then washed in distilled
water for 1 min and air-dried at 45 °C for 5–10 min. Finally,
the slides were cleared in xylene (Vetec) for 1 min and
mounted in Entellan® (Merck).BrdU labeling and detection
Cell proliferation was assessed using the thymidine analog,
5-bromo-2′-deoxy-uridine (BrdU). BrdU (50 mg/kg in 0.007%
NaOH in saline, Sigma) was injected 4 times at 3-h intervals,
6 days after the surgical procedure, and the animals were
euthanized 12 h after the last injection. To reveal BrdU-
positive cells, sections were incubated with a solution of HCL
(2 N in distilled water) for 30 min, followed by a borate buffer
solution (0.1 M, pH 8.5) for 10 min, both at 37 °C. Then, the
sections were rinsed with 0.3% Triton X-100 in PBS and
incubated in the blocking solution for 1 h at room tempera-
ture. After that, they were incubated with the primary
antibody (rat monoclonal antibody against BrdU, 1:100,
Abcam, Cambridge, MA, USA) overnight at 4 °C, followed by
incubation with the secondary antibody (goat anti-rat conju-
gated with Alexa 488, 1:200, Invitrogen) for 2 h.
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cytochemistry, using the cell proliferation marker Ki67. For
this, the sections were incubated in a 10 mM citrate buffer
solution, pH 6.0 and heated at 100 °C in amicrowave. Sections
were immediately transferred to a new container containing
iced distilled water for 5 min, washed 3 times in 0.3% Triton in
PBS for 3 min each time, and blocked with 5% NGS for 30 min.
Incubation with the primary antibody (rabbit polyclonal
antibody against Ki67, 1:400, Abcam)was performed overnight
at 4 °C, followed by incubation with the secondary antibody
(goat anti-rabbit conjugated with Cy3®, 1:500, Jackson
ImmunoResearch) for 2 h at room temperature.
Quantification and statistical analysis
We quantified blindly vimentin-positive cell processes around
the LVs, from six coronal sections from each animal (20 μm)
taken from each region along the rostro-caudal axis: rostral
(+2.2 mm to +1.37 mm from the bregma), intermediate
(+1.37 mm to +0.54 mm from the bregma) and caudal
(+0.54 mm to −0.3 mm from the bregma). Counts were
made using a 40× objective on a Zeiss Axiovert 200 M
microscope equipped with Apotome slide and fluorescence
optics (Zeiss, GmbH, Germany). Only vimentin-positive pro-
cesses longer than 80 μm were counted. The LV was divided
into three regions (lateral wall, medial wall and ventral
region) and the counts were made in each region individually.
Cells proliferating in the lateral wall of the LV with Ki67
staining or BrdU incorporation were counted in four coronal
sections from each animal (20 μm thick), taken from each
region (described above) along the rostro-caudal axis, using
the same microscope and objective. For the NG2 quantifica-
tion, we analyzed eight optical confocal reconstructions,
section by section, approximately 15 μm from the lateral wall
of the LV of each animal.
To quantify the association of RGLCs and blood vessels,
we stained the radial process for vimentin and the blood
vessels for laminin. We have used two 60 μm thick cryocuts
per animal and counts were made using an oil 40×1.3 n.a.
objective on a confocal microscope (Zeiss LSM 510 Meta).
Statistical analysis was performed by ANOVA and Newman–
Keuls post-test in GraphPad Prism 4.02 (1992–2004, GraphPad
Software, Inc.). The level of statistical significance used was
p≤0.05.
Immunoblotting analysis
MBP expression was quantified by immunoblotting assay. For
that, the animals in three different conditions (sham, BCCL
and BCCL+BMMC, n=3 in each group) were anesthetized and
sacrificed seven days after the surgery. The optic tract was
carefully dissected and the tissue was homogenized in a lysis
buffer (20 mM Tris–HCL pH 7.4; 150 mM NaCl; 2 mM EDTA;
0.2% Triton X-100; 1:1000 of Protease Inhibitor Cocktail Set III
[Calbiochem]). The samples were centrifuged at 13,000 ×g for
15 min at 4 °C. The supernatant was collected and the protein
concentration was measured by Bradford's assay (Bradford,
1976).
Thirty micrograms of protein was loaded in a 15% SDS-PAGE
and transferred to a nitrocellulose membrane (Amersham
Biosciences, Pittsburgh, PA, USA). For the immunoblotting,the membranes were blocked with PBS containing 0.05%
Tween-20 (Sigma) and 5% non-fat milk for 1 h. Posteriorly,
the membranes were washed with PBS 0.05% Tween-20 and
incubated with primary antibody against MBP (1:3000, Abcam)
and α-tubulin (1:40,000, Sigma) in PBS 0.05% Tween-20 and
0.1% non-fat milk for 3 h. After washing, the membranes
were incubated with HRP-conjugated rat secondary antibody
(1:4000, GE Healthcare) and HRP-conjugatedmouse secondary
antibody (1:3000, Sigma), respectively. The immunoreactive
bands were visualized using ECL-kit (Amersham Biosciences).
The relative intensity of the bands was analyzed using Image
J software (NIH).
Reverse transcription and polymerase chain reaction
(PCR)
For the analysis of growth factors expressed in the SVZ after
cell transplantation, the SVZ of sham and ischemic animals was
dissected 3 or 7 days post-surgery. The RNA was extracted
from the SVZ using TRIzol reagent (Invitrogen). Two micro-
grams of RNA was treated with DNase I (Invitrogen). Comple-
mentary DNA (cDNA) was synthesized using the enzyme
Superscript II Reverse Transcriptase (Invitrogen) and OligodT18
(IDT, Coralville, IA, USA). PCR reactions were performed with
Platinum® Taq DNA Polymerase (Invitrogen). Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was amplified using the
dissociation temperature of 60 °C. Brain-derived neurotrophic
factor (BDNF) was amplified using the dissociation tempera-
ture of 63 °C. PCR products were analyzed on 1.5% agarose gel
and labeled with ethidium bromide. GAPDH was used as an
internal amplification control. Primer sequences follow: BDNF
5′-AATGCTCACACAACACTGCCCA and 5′-GGAGGAGGGAGGGAA
AGAATGT; GAPDH 5′-ATCAAGAAGGTGGTGAAGCAGG and 5′-AG
GTGGAAGAGTGGGAGTTGCT.
Quantitative real-time PCR (Q-PCR)
BDNF mRNA levels were measured using 1× of Power SYBR
Green PCR Master Mix® (Applied Biosystems, Foster City, CA,
USA) and 0.5 μM of each primer. PCR reactions were
performed in a Corbett Rotor Gene 6000 thermal cycler.
The PCR protocol was performed with 10 min incubation at
95 °C and 60 cycles of 20 s at 95 °C and 1 min at 60 °C. The
mRNA levels of BDNF were normalized with the mRNA levels
of GAPDH. The mRNA levels were calculated using the
standard curve that was constructed using the DDCt method.
Statistical analysis was performed in GraphPad Prism 4
software, using one-way nonparametric ANOVA with Dunn's
post-test.
Results
Brain lesion after global ischemia
The animals were separated into four groups: sham-operated
(n=18); sham-operated that received the BMMC transplant
(sham+BMMC, n=12); BCCL animals (n=24); and BCCL animals
that received the BMMC transplant (BCCL+BMMC, n=23).
The effect of global ischemia (BCCL) in the brain was
investigated 3 days after lesion, by histochemical methods.
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istry, and 3 days after lesion, we observed strong staining in
the optic tract in every BCCL animal (Figs. 1B, C). This
staining was absent in the sham-operated group (Fig. 1A).
Seven days after BCCL, FluoroJade C staining could no longer
be observed in the optic tract (data not shown), demon-
strating that the cell damage occurred soon after the
occlusion. The optic tract staining suggests the presence of
axonal damage, since FluoroJade C labels dying neuronal
cell bodies, but also stains damaged axons. To verify if there
was also oligodendrocyte damage in this region, we did a
western blotting for myelin basic protein (MBP). We
observed a decrease in the MBP expression in the BCCL
animals compared to the sham animals 7 days after the
surgery (pb0.05, n=3) (Figs. 1D, E). In this respect, white-
matter lesion has been consistently described with other
methods in this model (Farkas et al., 2004; Ohta et al.,
1997). These results indicate that in adult Lister Hooded
rats, the BCCL procedure generates a reliable lesion in the
white matter.Characterization and bio-distribution of bone-marrow
cells after intravenous transplantation
BMMCs were characterized by flow cytometry, to determine
the percentage of different cell types in the mononuclearFigure 1 Brain lesion after BCCL. (A–C) Confocal images of the o
BCCL, showing FluoroJade C staining in the optic-tract region (delim
the B figure to illustrate the staining pattern in axons (arrows). Scale
lysates from the sham (n=3), BCCL (n=3) and BCCL+BMMC (n=3) gr
Alpha-tubulin was used as a loading control. (D) Data represent
alpha-tubulin. Error bars show the SEM for each experiment. We can
to sham. This difference was not observed comparing BCCL+BMMC
bands for MBP (lower panels) and alpha-tubulin (upper panels). #pbfraction (n=3). The characterization was done considering the
expression of antigen markers and the morphological charac-
teristics of the cells. We also analyzed the viability of BMMCs,
using propidium iodide incorporation. Briefly, we demonstrat-
ed that approximately 98% of the cells were viable before
transplantation. We also showed that 94.5%±2.1 of the cells
in the BMMC fraction derived from the hematopoietic
lineage, in which approximately 24.3%±3.7 were lympho-
cytes, 55.7%±0.07 were granulocytes and 16.5%±2.8 were
monocytes. Finally, we showed that 3.2%±1.9 of the cells in
the BMMC fraction expressed CD90 and were negative for
CD45. CD90 is considered a positive marker for mesenchymal
stem cells. This result suggests that this population may
contain mesenchymal stem cells, because they satisfy one of
the standard criteria used by the International Society for
Cellular Therapy (Dominici et al., 2006).
Migration and homing of the Tc99m-labeled BMMCs were
evaluated by scintillography 1 h after transplantation in the
BCCL animals. Labelingwas present in several organs, with the
highest uptake in the liver, spleen and bladder (Fig. 2A). It is
possible that some cells had already migrated to the head
region 1 h post-transplant. However, because of its short half
life (6–8 h), Tc99m does not allow an extended and detailed
analysis of BMMC distribution in the brain. Alternatively, for
long-term tracing, BMMCs were pre-labeled with Cell Trace
and the frozen sections of the brain were analyzed by
immunofluorescence 7 days after injection. In all animals,ptic tract in sham (A) and BCCL animals (B, C) 3 days after the
ited by lines) in the lesioned animals. (C) High magnification of
bar: (A, B) 20 μm, (C) 10 μm. (D, E) Western blot of optic-tract
oups 7 days after surgery, using specific antibodies against MBP.
ing the ratios of densitometric values of the MBP bands for
notice a decrease of MBP expression in BCCL animals compared
animals to sham. (E) Representative images of the respective
0.05.
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however, they were dispersed through the entire encephalon,
including the thalamus (Fig. 2C) and the cerebellum (Fig. 2B).
The labeled BMMCs were observed mainly near blood vessels
(Fig. 2B).
BMMCs promote proliferation of cells in the SVZ in
the BCCL animals
Cell proliferation around the LV was investigated by Ki67
immunolabeling (Figs. 3A–D) and BrdU incorporation (Fig. 3E).
BrdU was injected intraperitoneally six days after BCCL, and
BrdU-positive cells were quantified in the SVZ 7 days after
injury. We observed a slight increase in the number of
BrdU-positive cells in the BCCL group compared with the
shamanimals, but this increasewas not statistically significant
(sham: 60.9±10.45; n=3; BCCL: 78.9±13.82; n=4, p=0.058).
However, the number of BrdU-positive cells was significantly
higher in the BCCL animals that received the BMMC treatment
(BCCL+BMMC) when compared with the sham animals
(BCCL+BMMC: 91.5±8.41; n=3, pb0.05 vs sham: 60.9±
10.45) (Fig. 3E).
Cell proliferation around the LV was also assessed by
immunostaining of Ki67, a transcription factor expressed
during all active phases of the cell cycle. Ki67-positive cells
were quantified in the different groups at 3, 7 and 21 days
post-surgery. The number of Ki67-positive cells was similar
in the untreated sham and BCCL animals at all three time
points (Figs. 3F, G, H). Treatment with BMMCs did not result
in differences in the proliferation 3 days after injury in any
of the groups (Fig. 3F). However, a significant increase in the
number of Ki67-positive cells was observed 7 days after the
lesion in the BCCL+BMMC animals when compared to the
sham animals (sham 122.59±13.1; n=7 vs BCCL+BMMC
192.58±14.49; n=6; pb0.01) or compared to the untreated
BCCL animals (132.46±10.52; n=5; pb0.05) (Fig. 3G). In
sham animals that received BMMC treatment, the number of
Ki67-positive cells increased slightly; however, this increase
was not statistically significant (167.51±17.57; n=4; p=
0.072).
After 21 days, the number of Ki67-positive cells was
similar in all the groups (Fig. 3H). These results indicate that
therapy with BMMCs stimulated a transitory increase in cell
proliferation in the SVZ, which peaked around the 7th day
after injury and treatment.
BMMCs increase the number of radial glia-like cells
in the SVZ
Radial glia-like cells (RGLCs) were quantified in the neuro-
genic regions of the adult brain, in order to evaluate whetherFigure 2 BMMC distribution in BCCL animals. (A) Scintigraphy
image to illustrate the whole-body distribution of BMMCs
labeled with technetium 99 m 1 h after injection into an animal
with BCCL. The cells are numerous in the liver and spleen (lower
box) and some in the head (upper box). (B, C) Cell Trace-labeled
BMMCs (red) can be observed 6 days after the transplant, dis-
tributed in different brain regions, in association with blood
vessels in the cerebellum (B) and thalamus (C). Scale bars:
(B) 20 μm; (C) 40 μm.global ischemia and/or cell therapy with BMMCs would have
any effect on these cells. RGLCs were identified in the adult
SVZ by morphology and vimentin immunocytochemistry as
Figure 3 Cell proliferation in the SVZ in the lateral wall of the LVs. (A–D) Immunostaining for Ki67 in the lateral wall of a sham
animal (A), sham+BMMC animal (B), BCCL animal (C) and BCCL+BMMC animal (D) 7 days after surgery. (E) Quantification of
BrdU-positive cells in the lateral wall 7 days after surgery. The number of labeled cells was significantly higher in the BCCL+BMMC
group than in the sham group (pb0.05), but did not differ from the untreated lesioned group. (F–H) Quantification of Ki67-positive
cells in the lateral wall of the LV 3 (F), 7 (G), or 21 (H) days after the surgery. The number of Ki67-positive cells did not differ among
the different groups, 3 and 21 days after surgery. However, 7 days after surgery, the number of Ki67-positive cells in the BCCL+BMMC
animals increased compared with the sham (pb0.01) and BCCL animals (pb0.05). This result demonstrates a transitory effect of
BMMC treatment after BCCL in the SVZ proliferating cells. Scale bar: 50 μm.
247BMMCs therapy after ischemia induces RGLCs differentiation and progenitor rescue in SVZpreviously described (Gubert et al., 2009), and we quantified
the number of vimentin-positive radial processes (N80 μm)
extending from the walls (lateral, ventral and medial) of the
LV (Fig. 4). Our data showed that 3 days post-surgery, the
number of RGLCs in the lateral wall of the LV increased
significantly in the BCCL animals (43.51±3.08; n=6) compared
to the sham animals (27.88±1.98; n=12; pb0.01) (Figs. 4A, C,
M). These results are in accordance with a previous study that
used a different model, and found an increase in RGLCs around
the LV of adult rats a few days after focal ischemia (Zhang
et al., 2007). We observed a similar increase in the number of
RGLCs in the BCCL animals treated with BMMCs (BCCL+BMMC:
42.73±4.55; n=6), but there was no difference in the number
of RGLCs in the sham+BMMC animals compared with the
sham animals (sham+BMMC: 28.29±1.29; n=4 vs sham:
27.88±1.98) (Figs. 4A–D, M).
Seven days post-surgery, the number of RGLCs in the
untreated BCCL and sham groups was similar, suggesting that
the increase observed 3 days after surgery in the BCCL group
was transitory (Figs. 4E, G, N). However, the increase in the
number of RGLCs observed in the BCCL+BMMC group 3 days
after surgery was significantly higher compared with the
untreated BCCL or sham groups (BCCL+BMMC: 50.03±7.12;
n=4 vs sham: 27.88±1.98; n=12; pb0.05; BCCL: 25.73±3.66;
n=4; pb0.01) (Figs. 4E, H, N). In sham animals that were
transplanted with BMMCs, 7 days after surgery we observed
a slight increase in the number of RGLCs compared to the
untreated groups, but this increase was not statisticallysignificant (sham+BMMC: 40.35±5.19; n=5 vs sham: 27.88±
1.98, p=0.0512) (Figs. 4F, N).
To investigate if the BMMC treatment was able to stimulate
an increase in the number of RGLCs after a long period, we
analyzed the number of RGLCs 21 days post-surgery. At this
time point, we observed an increase in the number of RGLCs in
the lateral wall in the BCCL+BMMC group compared to the
sham animals (55.89±11.18; n=5 vs sham: 27.88±1.98; n=12;
pb0.05), but we did not observe a significant difference in the
number of RGLCs in the BCCL animals that did not receive
the transplant (35.93±10.5; n=5) (Figs. 4I, K, L, O). In the
sham+BMMC group, the number of RGLCs increased compared
to the sham untreated animals (51.28±6.36; n=4; pb0.05)
(Figs. 4I, J, O). These results demonstrated that the BMMC
treatment gradually increases the number of RGLCs around the
LV, and that this effect is not dependent on a lesion, although
it seems to be accelerated by it (Supplemental Fig. 1).
In the same experimental groups, we also analyzed the
number of RGLCs in the medial and ventral walls of the LV at
the same time points (3, 7 and 21 days post-surgery). We
observed no differences among the groups at any of the 3
time points. These results indicate that RGLCs around the LV
are heterogeneous and respond differently to BCCL and to
treatment with BMMCs.
In our previous study we showed that RGLCs express other
proteins in common with development radial glia, such as
nestin, Pax6 and GLAST (Gubert et al., 2009). We observed
that seven days after BCCL, rats that were treated with
248 F. Gubert et al.BMMCs also, by a qualitative evaluation, have an increase in
the number of radial processes stained with nestin compared
with the untreated BCCL animals (Supplemental Fig. 2). It isFigure 4 RGLCs in the SVZ in the lateral wall of the LVs. (A–L) RGLC
(A, E, I), sham+BMMC animal (B, F, J), BCCL animal (C, G, K) and BCC
number of vimentin-positive radial processes increased in the BCCL
groups at this time point. (E–H) The number of vimentin-positive rad
to the untreated animals. (I–L) The number of vimentin-positive radi
point compared with the sham animals. (M–O) Quantification of vim
7 (N) or 21 (O) days post-surgery. The number of RGLCs was signific
group, at each time point. The number of RGLCs in the untreated BCC
to that of the sham animals, but this difference disappeared in the spossible to observe that some RGLC nestin-positive also
express Ki67, demonstrating their proliferative capacity
(Supplemental Fig. 2F').s immunostained for vimentin in the lateral wall of a sham animal
L+BMMC animal (D, H, L) after different time periods. (A–D) The
(C) and BCCL+BMMC (D) animals compared with the other two
ial processes increased in the BCCL+BMMC (H) animals compared
al processes increased in the BCCL+BMMC (L) animals at this time
entin-positive processes extending from the lateral wall, 3 (M),
antly higher in the BCCL+BMMC group compared with the sham
L animals 3 days after ischemia was significantly higher compared
ubsequent days. #pb0.05; *pb0.01. Scale bar: 50 μm.
249BMMCs therapy after ischemia induces RGLCs differentiation and progenitor rescue in SVZOne interesting characteristic observed in the RGLCs is
their proximity/contact with blood vessels. To evaluate how
frequent this event occurs and if it is disturbed by the BCCL
and/or BMMC transplant, we quantified by confocal micros-
copy the number of RGLCs in contact with blood vessels. Our
data showed that in the sham animals a high percentage of
vimentin-positive radial process (68.51±2.32%; n=3) have
contact with laminin-stained blood vessels. This percentage
was not altered neither in the BCCL (68.94±2.32% n=3) or in
the BCCL animals treated with BMMCs (71.7±1.99% n=3)
(Fig. 5).
BMMC transplantation protects against NG2-postive
cells lost in the SVZ
It is widely reported in the literature that one of the first
regions affected by the BCCL procedure is the white matter,
where it is possible to observe the degeneration of oligoden-
drocytes (Farkas et al., 2004; Kurumatani et al., 1998; Wakita
et al., 2002). In order to determine if this loss could affect the
oligodendrocyte progenitors located in the SVZ, we quantified
the number of NG2-positive cells in this region 7 days after
BCCL. After the ischemia, we observed an approximately
1.8-fold reduction in the number of NG2-positive cells com-
pared to the sham animals (0.544±0.21 vs sham 1±0.23; n=5;
pb0.05) (Figs. 6A, B, D). However, in the BCCL animals
treated with BMMCs, no reduction was observed, and the
number of NG2-positive cells remained similar to that of the
sham animals (0.82±0.34; n=6) (Figs. 6A, C, D). This result
indicates that the cell therapy protects the oligodendrocyte
progenitors after a cerebral hypoperfusion.
It is interesting to notice that, similar to the NG2 analysis,
we did not observe a decrease in the MBP expression in the
optic tract of the BCCL+BMMC animals compared with sham
animals, as we observed in the untreated rats (Fig. 1).
Increase in BDNF expression in the SVZ after BMMC
therapy
In order to investigate whether BMMC therapy modulates
the expression of trophic or growth factors in the SVZ of
the BCCL animals, we analyzed the mRNA levels of VEGF,
BDNF, transforming growth factor alpha (TGF-α), ciliary
neurotrophic factor (CNTF) and FGF-2 at 3 and 7 days after
surgery. We observed no significant differences in the levels
of VEGF, TGF-α, CNTF and FGF-2 among the different groups
at any time point (data not shown). However, 3 days after
lesion, the mRNA levels of BDNF increased in the BCCL
animals that received the BMMC transplantation, compared
to the untreated BCCL animals (Fig. 7G, pb0.01). Seven days
after BCCL, the mRNA levels of BDNF were still higher in
the BCCL+BMMC animals, compared to those in sham and
BCCL animals that did not receive the treatment (Fig. 7H,
pb0.01). At this time point, we also observed an increase
in BDNF mRNA levels in sham+BMMC animals compared
to sham and BCCL animals (Fig. 7H, pb0.05). This increase
was observed by both semi-quantitative PCR (Fig. 7I) and
quantitative real-time PCR (Fig. 7H).
In order to further investigate the role of BDNF, we
analyzed the protein expression by means of immunohisto-
chemistry. In agreement with the results from the mRNA, theBDNF expression increased in the SVZ of the BCCL+BMMC
group (Fig. 7E) compared to the untreated groups (Fig. 7B).
However, we did not observe an increase in BDNF expression
in the sham+BMMC animals (data not shown), as we observed
in the RNA analysis at this time point. At the cellular level,
BDNF was expressed in cell bodies of vimentin-positive cells in
the SVZ in the BCCL+BMMC animals (Figs. 7D–F, arrowhead)
and in some cases also in RGLC processes (Figs. 7D–F, arrows).
These data indicate that BMMC transplantation stimulated an
increase in both BDNFmRNA and protein levels in the SVZ cells
in the injured animals, but not in the sham animals.
Discussion
Several studies have demonstrated the benefits of bone-
marrow cell transplantation in different models of brain
ischemia, as well as in other brain injuries (de Vasconcelos
Dos Santos et al., 2010; Qu et al., 2008; Zaverucha-do-Valle
et al., 2011). In our study, we used a model of global
ischemia to investigate the responses of the adult neuro-
genic niche to cell therapy with BMMCs.
We demonstrated that bone-marrow cell therapy after
global ischemia in adult rats induced a transitory increase in
cell proliferation in the SVZ of the lateral wall of the LV. In
addition, the number of RGLCs in the SVZ progressively
increased. The BMMC treatment also restored the number of
oligodendrocyte precursors that were lost in the BCCL
animals. Finally, we demonstrated up-regulation of BDNF
expression after treatment, suggesting that this factor might
be mediating the effects of cell therapy.
Cell therapies have been proposed as an attempt to
increase NSC proliferation, differentiation, and/or cell sur-
vival, and consequently functional improvement after ische-
mic lesions in the adult brain. Bonemarrow-derived stem cells
have been used in these models, and several reports have
shown that, despite the small number of transplanted cells
that reach the lesion area, this therapy results in functional
benefits in the treated animals (Borlongan et al., 2004; Ohtaki
et al., 2008; Vasconcelos-Dos-Santos et al., 2012). The BMMC
fraction includes both hematopoietic and mesenchymal stem
cells, several progenitors, and differentiated bone-marrow
cells. Both BMMCs and mesenchymal cells have been used in a
model of focal ischemia in adult rats, with similar beneficial
functional effects (de Vasconcelos Dos Santos et al., 2010).
However, in a clinical setting, the BMMC fraction might be
safer than MSCs, since these cells are obtained after several
passages. For these reasons, in this study we investigated the
mechanisms of action of BMMCs.
Several mechanisms have been suggested to explain the
functional benefits after bone-marrow cell therapy, and
among these, it has been suggested that these cells could
modulate the NSCs in order to increase endogenous
regeneration after injury. In this study, we assessed the
presence of RGLCs in different groups: sham, sham+BMMC
treatment, BCCL, and BCCL+BMMC. During development,
radial glia cells play an important role as NSCs and as a
migration guide for the newly born neurons (Malatesta et al.,
2003; Noctor et al., 2001; Parnavelas and Nadarajah, 2001).
In the adult, RGLCs also seem to play a role as NSCs in the
two main neurogenic regions, the SVZ and the SGL (Mirzadeh
et al., 2008; Shapiro et al., 2005).
Figure 5 RGLC processes associated with blood vessels around the LVs. (A) Photomontage of confocal images of the lateral wall of
the LV and the adjacent striatum in a coronal section of a BCCL+BMMC animal showing vimentin-positive radial processes (red) in
contact with blood vessels stained for laminin (green). The white boxes in A show in higher magnification the association of the RGLC
process with the blood vessels in the dorsal (B), medial (C) and ventral (D) striatum. Scale bar: (A) 200 μm, (B, D) 50 μm and (C) 25 μm.
250 F. Gubert et al.The presence of RGLCs was investigated using vimentin,
as previously described by our group (Gubert et al., 2009).
Vimentin is an intermediate filament protein expressed in
glial cells, especially radial glia cells during development,
and it is highly expressed in the RGLCs in the adult. In controlanimals, we observed vimentin-positive cells around the LV,
staining the ependymal layer and RGLC processes extending
from the walls of the LV, as previously described (Gubert et
al., 2009). In the current study, we observed an increase in
the number of RGLCs on the third day after BCCL in animals
251BMMCs therapy after ischemia induces RGLCs differentiation and progenitor rescue in SVZthat did or did not receive the BMMC transplant. However,
this increase persisted until 21 days after injury only in the
animals that received the transplant.
In 2007, Zhang and co-workers demonstrated that
ependymal cells proliferate and transform into RGLCs
1–2 days after a stroke. Seven days after injury, fewer
RGLCs were observed (Zhang et al., 2007). These findings
concord with our observation that after BCCL, the number
of RGLCs increased temporarily. However, in animals that
received BMMC treatment, we observed more radial cells
for a longer period (at least until 21 days). This suggests
that BCCL and BMMCs stimulate the cells in the lateral
wall differently. BCCL could be stimulating the transitory
transformation of ependymal cells, and BMMCs could be
stimulating the proliferation of RGLCs in the SVZ. In ac-
cordance with this hypothesis, we observed an increase in
cell proliferation in the SVZ 7 days after BCCL only in the
animals that received the transplant. Importantly, the
number of RGLCs progressively increased in the sham
animals that received the BMMC transplant. This result
also supports the idea that two different stimuli can cause
an increase in the number of RGLCs, since we observed this
event even in uninjured animals.Figure 6 NG2-positive cells in the SVZ in the lateral wall of the LV
(A), BCCL animal (B) and BCCL+BMMC animal (C). (D) Quantificatio
number of NG2-positive radial processes decreased in the BCCL group
in the BCCL+BMMC. *pb0.05. Scale bar: 20 μm.Gregg and Weiss (2003) demonstrated that intraventricular
injection of EGF and TGF-α induces the generation of RGLCs
in the SVZ in adult mice. Zhou et al. (2001) demonstrated
that TGF-α induces, in vitro, the differentiation of mature
astrocytes into radial cells. We analyzed the levels of TGF-α
mRNA in the SVZ, and observed no differences among the
groups over the time period investigated. It is possible that
in our model, the increase in the number of RGLCs occurs
by proliferation rather than differentiation of astrocytes (or
ependymal cells) into RGLCs, since we observed an increase in
both RGLCs and Ki67 in the lateral wall 7 days after injury
in the animals that received BMMC therapy. We attempted
to quantify the number of proliferative RGLCs by analyzing
the expression of nestin and Ki67 by confocal microscopy, in
800–900 nm optical sections. In our previous study we demon-
strated that RGLCs express nestin, a neural progenitor marker,
although this stain is weaker than vimentin (Gubert et al.,
2009). This characteristic could help us to distinguish the cell
body of each radial process. Seven days post-surgery, we
observed an increase in the number of nestin-positive pro-
cesses in the BCCL+BMMC animals, as also observed with the
vimentin staining (Supplemental Fig. 2). However, the SVZ is a
dense cell layer, with many cells expressing nestin. Becauses. Immunostaining for NG2 in the lateral wall, for a sham animal
n of NG2-positive cells in the SVZ, 7 days after ischemia. The
compared to the sham group. No similar reduction was observed
252 F. Gubert et al.the radial process is thin and tortuous, it was not possible to
determine, in most cases, to which Ki67-positive cell body the
process belongs.
In a recent work from our group, it was shown that after
a focal ischemia, most of the BMMCs migrate to internal
organs, such as the liver and lungs. However, the small
percentage of cells that reach the brain parenchyma migrate
preferentially to the lesion site (Vasconcelos-Dos-Santos et
al., 2012). In our work, we observed a similar distribution of
the transplanted cells into the liver and lungs, however since
we did not perform a localized injury it was not possible toFigure 7 BDNF mRNA and protein levels in the SVZ are modulated
(A, D) and BDNF (B, E) in the SVZ, 7 days post-surgery in BCCL+BMM
BDNF in the sham group (B) and an increased expression in the BCCL+
in the radial processes of RGLCs (arrows) and in the cell bodies (arro
semi-quantitative PCR (I) and quantitative PCR (G, H) in all experime
increased at 3 and 7 days after ischemia in the BCCL+BMMC animalidentify a brain region where the BMMCs would be
preferentially confined. Even though we observed few
BMMCs in the brain, there is some hypothesis that could
explain how these cells are affecting the SVZ cells. First, it is
possible that the number of BMMCs that infiltrate and
survive into the brain would be enough to play this role
through a paracrine signaling. A second possibility is through
a “touch-and-go” mechanism, where the BMMCs would
migrate to the injury site, release signals/molecules and
then be cleared (for review see Uccelli et al., 2008).
Moreover, we observed that the majority of RGLCs in theby BMMC therapy. Confocal images of vimentin immunolabeling
C (D–F) and sham animals (A–C). Observe the weak staining for
BMMC (E) animals. (D–F) Illustration of a co-localization of BDNF
whead). Scale bar: 20 μm. (G–I) BDNF mRNA levels analyzed by
ntal groups at 3 and 7 days post-surgery. The levels of BDNF are
s. #pb0.05; *pb0.01.
253BMMCs therapy after ischemia induces RGLCs differentiation and progenitor rescue in SVZSVZ have a prominent contact/interaction with the blood
vessels. Therefore, it would be possible to speculate that
this interaction could transduce signals from the blood
stream to the brain parenchyma through the RGLC
processes.
Our hypothesis is that BMMCs release cytokines and growth
factors that could stimulate the proliferation and differenti-
ation of SVZ cells. Bone-marrow cells express a wide range
of factors, such as VEGF, BDNF, FGF-2, glial cell-derived
neurotrophic factor (GDNF), nerve growth factor (NGF) and
hepatocyte growth factor (HGF), and they respond to an
inflammation or injury by enhancing this expression (Chen et
al., 2002; Kurozumi et al., 2005; Labouyrie et al., 1999;
Ribeiro-Resende et al., 2009; Wang et al., 2006; Zaverucha-
do-Valle et al., 2011). In addition, several other studies have
demonstrated that bone-marrow cells can also modulate
the expression of growth factor by neural cells, similarly to
astrocytes (Gao et al., 2005; Gao et al., 2008).
We analyzed the levels of several growth factors in the
SVZ 3 and 7 days post-surgery. BDNF expression increased in
the treated animals 3 days after the lesion and remained
higher for at least 7 days. Importantly, in the retina, Müller
cells express BDNF, and this expression has been correlated
with neuroprotection of retinal ganglion cells (Seki et al.,
2005). Hence, in our model it is possible that RGLCs express
BDNF, since we observed vimentin-positive radial processes
labeled for BDNF. We also found that both the number of
RGLCs and the levels of BDNF expression increased over the
same period of time in the BCCL animals that received BMMC
treatment. The increase in BDNF mRNA levels was observed
also in the sham+BMMC animals, although the protein
expression did not increase. Since, in this group, we only
observed an increase in mRNA 7 days after the insult,
differently from the BCCL+BMMC animals that showed the
increase after only 3 days, it is possible that the increase in the
protein expression could be observed only at later time points.
The role of BDNF in the adult SVZ has been analyzed by
different groups with controversial results. Most studies with
BDNF infusions or overexpression in the lateral ventricle
demonstrated an increase in the number of newly born
neurons in the olfactory bulb. However, Alvarez-Buylla's
group showed that BDNF did not affect the neurons' survival
in mice while in rats it decreases neuronal survival (for
review see Bath et al., 2011). BDNF or its receptors, have
also been associated with cell proliferation and neuronal
migration (Bath et al., 2011). In the present study, we
observed an increase in BDNF expression in the SVZ after the
BMMC transplant. Therefore, it would be of interest to
analyze if BDNF by itself could be responsible for the effects
on proliferation and RGLC differentiation described here.
In injuries where the lesion occurs in the white matter,
some groups demonstrated that the number of oligodendro-
cyte precursors in the SVZ increases, and that these cells
could be migrating to the lesion area, as was observed
with neuroblasts (Menn et al., 2006; Talbott et al., 2005). In
our study, we showed white matter damage after BCCL,
followed by a reduction in the number of oligodendrocyte
progenitors in the SVZ. This contradictory response could be
explained by the fact that we submitted the entire brain to a
hypoperfusion that is known to affect oligodendrocytes
(Farkas et al., 2004; Wakita et al., 2002), differently from
the other studies, which induced a localized lesion in thewhite matter. Models of neonatal hypoperfusion have also
shown a reduction in the number of NG2-positive cells,
demonstrating how these cells are susceptible to hypoxia
(Rothstein and Levison, 2005).
After BCCL, we observed a decrease in the number of
NG2-positive cells, but the BMMC therapy restored this number.
This result indicates that these cells protect the oligodendro-
cyte progenitors against the injury. The same pattern was
observed in the analysis of MBP expression in the optic tract,
one of the most affected regions after BCCL. Seven days after
ischemia, BCCL animals showed a decrease in the MBP ex-
pression, while the animals that were treated with BMMC did
not show this reduction. In our model, the factor involved in
this event could be the BDNF, which, as discussed above, is
expressed more highly after BMMC transplantation. Previous
studies have shown that, after spinal-cord lesion, intrathe-
cal delivery of BDNF stimulates myelination and protects
the oligodendrocytes from apoptosis (Ikeda et al., 2002;
Koda et al., 2002). Also, injection of bone-marrow stem cells
overexpressing BDNF reduces demyelination and the number
of apoptotic cells in a model of encephalomyelitis (Makar
et al., 2008). Therefore, BDNF is probably one of the factors
involved in the NG2-cell protection that we observed in the
BCCL animals after the BMMC transplantation.
In this study, we observed that in animals that suffer
global ischemia and receive a BMMC transplant, the number
of RGLCs and protection of oligodendrocyte progenitors
in the SVZ increase. Although oligodendrocyte progenitors
migrate mainly through axon tracts, during development and
in some cases of injury it was demonstrated that these
progenitors could use radial migration (Diers-Fenger et al.,
2001; Suzuki and Goldman, 2003). Further analyses are
necessary in order to test the hypothesis based on these
indications, suggesting that, in our model, the RGLCs may be
acting as a support for the migration of the oligodendrocyte
progenitors to the lesion sites, for example the optic tract.
Conclusion
In the present work, we were able to show that a few days
after a moderate ischemia, bone-marrow cell therapy stimu-
lated cellular proliferation and an increase in the number of
RGLCs in the SVZ. The effect of the cell transplant stimulates
an increase in the number of RGLCs even in non injury animals.
The ischemia decreases the number of oligodendrocyte
progenitors in the SVZ; however, bone-marrow therapy
restored this number to control levels. In summary, our
results suggest that one of the possible mechanisms to
explain the functional benefits observed after cell therapies
with bone marrow-derived cells could involve protection of
oligodendrocyte progenitors and modulation of resident
NSCs, increasing their proliferation and possibly their
differentiation into RGLCs.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2012.11.009.
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